- Home
- TGE vs COYA Comparison
TGE vs COYA Comparison
Compare TGE & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGE
- COYA
- Stock Information
- Founded
- TGE 2023
- COYA 2020
- Country
- TGE France
- COYA United States
- Employees
- TGE N/A
- COYA N/A
- Industry
- TGE Newspapers/Magazines
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- TGE Consumer Discretionary
- COYA Health Care
- Exchange
- TGE Nasdaq
- COYA Nasdaq
- Market Cap
- TGE 120.2M
- COYA 107.0M
- IPO Year
- TGE N/A
- COYA 2022
- Fundamental
- Price
- TGE $2.12
- COYA $6.10
- Analyst Decision
- TGE
- COYA Strong Buy
- Analyst Count
- TGE 0
- COYA 5
- Target Price
- TGE N/A
- COYA $16.20
- AVG Volume (30 Days)
- TGE 1.1M
- COYA 85.7K
- Earning Date
- TGE 02-12-2020
- COYA 11-05-2025
- Dividend Yield
- TGE N/A
- COYA N/A
- EPS Growth
- TGE N/A
- COYA N/A
- EPS
- TGE 1.64
- COYA N/A
- Revenue
- TGE $77,014,000.00
- COYA $423,452.00
- Revenue This Year
- TGE N/A
- COYA $40.80
- Revenue Next Year
- TGE N/A
- COYA N/A
- P/E Ratio
- TGE $1.28
- COYA N/A
- Revenue Growth
- TGE 81.03
- COYA N/A
- 52 Week Low
- TGE $1.93
- COYA $4.65
- 52 Week High
- TGE $37.02
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- TGE N/A
- COYA 55.10
- Support Level
- TGE N/A
- COYA $5.10
- Resistance Level
- TGE N/A
- COYA $5.93
- Average True Range (ATR)
- TGE 0.00
- COYA 0.32
- MACD
- TGE 0.00
- COYA 0.06
- Stochastic Oscillator
- TGE 0.00
- COYA 91.75
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.